Business Context and Reporting Period
Company: BIO-RAD LABORATORIES, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: December 21, 2004
Event: Completion of a debt offering and entry into a material definitive agreement.
Key Financial Metrics
This filing reports the completion of a specific debt issuance rather than periodic operating results.
- Debt Issuance: $200,000,000 aggregate principal amount.
- Instrument: 6.125% Senior Subordinated Notes due 2014.
- Trustee: Wells Fargo Bank, National Association.
- Revenue, Profit, Cash Flow, Margins: The filing text does not provide a clear value for these operating metrics.
- Liquidity: The filing text does not provide a clear value for current liquidity positions, though the offering increases cash proceeds.
Material Changes Versus Prior Period
The primary material change is the creation of a new direct financial obligation. The Company has increased its long-term debt load by $200 million through the issuance of the Notes. No comparative operating data is provided in this specific report to assess changes in revenue or profitability.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the execution of the Indenture dated December 21, 2004. It states that the descriptions of the Indenture and Notes are qualified in their entirety by reference to the full Indenture filed as Exhibit 4.1.
Risks and Contingencies: The filing does not explicitly list new risks or contingencies beyond the standard obligations associated with the Senior Subordinated Notes. Investors are directed to the Indenture for complete terms and conditions.
Unusual Items: None reported beyond the scheduled debt offering.
Important Facts for Investor Verification
- Verify the full terms of the 6.125% Senior Subordinated Notes due 2014 in the Indenture (Exhibit 4.1).
- Confirm the use of proceeds from the $200 million offering in subsequent financial statements.
- Review the impact of the new debt service obligations on the Company's future cash flow and leverage ratios.
- Check for any covenants within the Indenture that may restrict future financial flexibility.